1. Short title This Act may be cited as the Long COVID Support Act . 2. Voluntary patient registry for research on Long COVID and related conditions (a) In general The Secretary of Health and Human Services (referred to in this Act as the Secretary ) shall carry out activities described in subsection (b) for treatment related to Long COVID and related conditions. (b) Activities described For purposes of subsection (a), activities described in this subsection shall include— (1) creating or maintaining a regularly updated voluntary patient registry of individuals with suspected or confirmed Long COVID and related conditions, including information on— (A) symptoms that arise while an individual is initially infected with COVID–19 and that may resolve over time or extend beyond the resolution of the initial symptoms; (B) persistent symptoms that arise after an individual is initially infected with COVID–19 and that the clinician of such individual has reason to suspect were related to the COVID–19 diagnosis; (C) symptoms that arise in an individual that may be related to COVID–19, but a diagnosis of COVID–19 was not obtained and cannot be identified due to a lack of antibodies, false negative test results, or lack of access to timely testing; (D) treatments of individuals after primary diagnosis of COVID–19 and the effectiveness of such treatments; (E) any other relevant questions or issues related to individuals who experience a diagnosis of, treatment for, and management of care with COVID–19, Long COVID, and related conditions; and (F) comorbidities, vaccination status, and demographics, including age, gender, race and ethnicity, geographic location, and occupation of registry participants; (2) information relating to individuals experiencing Long COVID and related conditions and other information available through the voluntary patient registry